作者
Grímur Hjörleifsson Eldjárn,Egil Ferkingstad,Sigrún H. Lund,Hannes Helgason,Ólafur Þ. Magnússon,Kristbjörg Gunnarsdóttir,Thorunn A. Olafsdottir,Bjarni V. Halldórsson,Pall I. Olason,Florian Zink,Sigurjón A. Guðjónsson,Garðar Sveinbjörnsson,Magnus I. Magnusson,Agnar Helgason,Ásmundur Oddsson,Gísli H. Halldórsson,Magnús K. Magnússon,Saedís Saevarsdóttir,Thjodbjorg Eiriksdottir,Gísli Másson,Hreinn Stefánsson,Ingileif Jónsdóttir,Hilma Hólm,Þórunn Rafnar,Páll Melsted,Jona Saemundsdottir,Gudmundur L. Norddahl,Guðmar Þorleifsson,Magnús Ö. Úlfarsson,Daníel F. Guðbjartsson,Unnur Þorsteinsdóttir,Patrick Sulem,Kári Stéfansson
摘要
High-throughput proteomics platforms measuring thousands of proteins in plasma combined with genomic and phenotypic information have the power to bridge the gap between the genome and diseases. Here we performed association studies of Olink Explore 3072 data generated by the UK Biobank Pharma Proteomics Project